+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Excipients for Taste Masking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 190 Pages
  • July 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5918336
The global pharmaceutical excipients for taste masking market is witnessing significant traction as the pharmaceutical industry continues to innovate patient-friendly oral dosage forms. According to a new analysis, the market is projected to grow from USD 1.01 billion in 2025 to USD 1.44 billion by 2032, expanding at a CAGR of 5.10% during the forecast period. The need for effective taste-masking technologies is growing in tandem with the rising consumption of bitter drugs such as antibiotics, analgesics, and anti-inflammatory medications.

Market Insights

Taste masking plays an integral role in ensuring patient compliance, particularly among pediatric and geriatric populations. These segments often face difficulty in swallowing or tolerating the unpleasant taste of certain active pharmaceutical ingredients (APIs). This has resulted in increasing reliance on pharmaceutical excipients designed to mask these flavors and improve the acceptability of oral medications. Artificial excipients and coating techniques remain at the forefront of this trend, providing manufacturers with scalable, efficient solutions to enhance the palatability and shelf life of their drug formulations.

Key Market Drivers

The pharmaceutical excipients for taste masking market is being driven by several key factors:

  • Rising Demand for Medication: The global burden of chronic and lifestyle diseases such as diabetes, cardiovascular disorders, and obesity has increased the overall consumption of oral medications. This trend has boosted demand for taste-masking agents that improve patient compliance, especially in long-term therapeutic regimens.
  • Evolving Formulation Technologies: Advancements in techniques such as hot melt extrusion, microencapsulation, and coating have significantly improved the efficiency and effectiveness of taste masking. These innovations help pharmaceutical companies address formulation challenges while delivering drugs that are both effective and palatable.

Business Opportunity

With continued innovation in excipient technologies, new opportunities are emerging for manufacturers. The increasing adoption of stimuli-responsive drug delivery systems and the development of bioavailability-enhancing excipients are reshaping the market. Furthermore, the expansion of online pharmacies and contract manufacturing organizations (CMOs) creates added avenues for product development and global reach.

The market also presents opportunities for companies to develop excipients specifically tailored for traditional medicine formats and pediatric formulations. For instance, taste-masking technologies are being integrated into Traditional Chinese Medicine (TCM) formulations to improve palatability for children-particularly for bitter flavonoids and alkaloid-based compounds.

Regional Analysis

  • United States: The U.S. is a leading market in North America, driven by a strong pharmaceutical manufacturing base, continual product innovation, and technological advancement. The launch of novel excipients like Apisolex has enhanced solubility in parenteral drug formulations and contributed to market growth.
  • Germany: As a major pharmaceutical hub in Europe, Germany is seeing increased demand for taste-masked formulations due to a rise in the patient population affected by chronic diseases. Investments in pharmaceutical manufacturing and nanotechnology are further fueling regional market expansion.
  • China: China dominates the East Asia market with extensive implementation of taste-masking excipients in traditional medicine. The incorporation of chitosan-based technologies for pediatric applications is improving drug adherence among younger patients and opening up new commercial possibilities.

Key Players

Prominent companies operating in the global pharmaceutical excipients for taste masking market are focusing on expanding their product portfolios and investing in R&D to develop advanced masking techniques. Notable players include:
  • SPI Pharma, Inc.
  • Adare Pharmaceutical Inc.
  • GPT Pharmaceuticals Pvt. Ltd
  • Roquette Frères
  • Rochem International, Inc.
  • Gattefose
  • Asahi Kasei Corporation
  • DuPont de Nemours, Inc
  • Dow Pharma Solutions
Strategic initiatives such as the introduction of galenIQ 721 by Beneo and the customized excipient solutions by CD Formulation demonstrate how key players are addressing solubility and palatability challenges with innovative products.

Market Segmentation

By Excipient Type

  • Natural
  • Artificial
  • Nutritive
  • Non-nutritive
  • Polyols
  • Others

By Technique

  • Hot Melt Extrusion
  • Microencapsulation
  • Coating
  • Organoleptic Methods
  • Others

By Usage

  • Solid Dosage Forms
  • Tablets
  • Granules
  • Capsules
  • Liquid Dosage Forms

By End User

  • Pharmaceuticals
  • Nutraceuticals
  • Contract Manufacturing Organizations

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Pharmaceutical Excipients for Taste Masking Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Pharmaceutical Excipients for Taste Masking Market Outlook, 2019-2032
3.1. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Natural
3.1.1.2. Artificial
3.1.1.3. Nutritive
3.1.1.4. Non- nutritive
3.1.1.5. Polyols
3.1.1.6. Others
3.2. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Hot Melt Extrusion
3.2.1.2. Microencapsulation
3.2.1.3. Coating
3.2.1.4. Organoleptic Methods
3.2.1.5. Others
3.3. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Solid Dosage Forms
3.3.1.1.1. Tablets
3.3.1.1.2. Granules
3.3.1.1.3. Capsules
3.3.1.2. Liquid Dosage Forms
3.4. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. Pharmaceuticals
3.4.1.2. Nutraceuticals
3.4.1.3. Contract Manufacturing Organizations
3.5. Global Pharmaceutical Excipients for Taste Masking Market Outlook, by Region, Value (US$ Mn), 2019-2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Pharmaceutical Excipients for Taste Masking Market Outlook, 2019-2032
4.1. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Natural
4.1.1.2. Artificial
4.1.1.3. Nutritive
4.1.1.4. Non- nutritive
4.1.1.5. Polyols
4.1.1.6. Others
4.2. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Hot Melt Extrusion
4.2.1.2. Microencapsulation
4.2.1.3. Coating
4.2.1.4. Organoleptic Methods
4.2.1.5. Others
4.3. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Solid Dosage Forms
4.3.1.1.1. Tablets
4.3.1.1.2. Granules
4.3.1.1.3. Capsules
4.3.1.2. Liquid Dosage Forms
4.4. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. Pharmaceuticals
4.4.1.2. Nutraceuticals
4.4.1.3. Contract Manufacturing Organizations
4.5. North America Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2019-2032
4.5.1. Key Highlights
4.5.1.1. U.S. Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
4.5.1.2. U.S. Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
4.5.1.3. U.S. Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
4.5.1.4. U.S. Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
4.5.1.5. Canada Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
4.5.1.6. Canada Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
4.5.1.7. Canada Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
4.5.1.8. Canada Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, 2019-2032
5.1. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Natural
5.1.1.2. Artificial
5.1.1.3. Nutritive
5.1.1.4. Non- nutritive
5.1.1.5. Polyols
5.1.1.6. Others
5.2. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Hot Melt Extrusion
5.2.1.2. Microencapsulation
5.2.1.3. Coating
5.2.1.4. Organoleptic Methods
5.2.1.5. Others
5.3. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Solid Dosage Forms
5.3.1.1.1. Tablets
5.3.1.1.2. Granules
5.3.1.1.3. Capsules
5.3.1.2. Liquid Dosage Forms
5.4. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Pharmaceuticals
5.4.1.2. Nutraceuticals
5.4.1.3. Contract Manufacturing Organizations
5.5. Europe Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2019-2032
5.5.1. Key Highlights
5.5.1.1. Germany Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
5.5.1.2. Germany Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
5.5.1.3. Germany Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
5.5.1.4. Germany Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
5.5.1.5. U.K. Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
5.5.1.6. U.K. Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
5.5.1.7. U.K. Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
5.5.1.8. U.K. Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
5.5.1.9. France Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
5.5.1.10. France Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
5.5.1.11. France Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
5.5.1.12. France Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
5.5.1.13. Italy Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
5.5.1.14. Italy Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
5.5.1.15. Italy Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
5.5.1.16. Italy Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
5.5.1.17. Turkey Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
5.5.1.18. Turkey Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
5.5.1.19. Turkey Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
5.5.1.20. Turkey Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
5.5.1.21. Russia Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
5.5.1.22. Russia Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
5.5.1.23. Russia Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
5.5.1.24. Russia Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
5.5.1.25. Rest of Europe Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
5.5.1.26. Rest of Europe Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
5.5.1.27. Rest of Europe Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
5.5.1.28. Rest of Europe Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, 2019-2032
6.1. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Natural
6.1.1.2. Artificial
6.1.1.3. Nutritive
6.1.1.4. Non- nutritive
6.1.1.5. Polyols
6.1.1.6. Others
6.2. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Hot Melt Extrusion
6.2.1.2. Microencapsulation
6.2.1.3. Coating
6.2.1.4. Organoleptic Methods
6.2.1.5. Others
6.3. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Solid Dosage Forms
6.3.1.1.1. Tablets
6.3.1.1.2. Granules
6.3.1.1.3. Capsules
6.3.1.2. Liquid Dosage Forms
6.4. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Pharmaceuticals
6.4.1.2. Nutraceuticals
6.4.1.3. Contract Manufacturing Organizations
6.5. Asia Pacific Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2019-2032
6.5.1. Key Highlights
6.5.1.1. China Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
6.5.1.2. China Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
6.5.1.3. China Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
6.5.1.4. China Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
6.5.1.5. Japan Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
6.5.1.6. Japan Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
6.5.1.7. Japan Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
6.5.1.8. Japan Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
6.5.1.9. South Korea Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
6.5.1.10. South Korea Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
6.5.1.11. South Korea Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
6.5.1.12. South Korea Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
6.5.1.13. India Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
6.5.1.14. India Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
6.5.1.15. India Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
6.5.1.16. India Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
6.5.1.17. Southeast Asia Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
6.5.1.18. Southeast Asia Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
6.5.1.19. Southeast Asia Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
6.5.1.20. Southeast Asia Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
6.5.1.21. Rest of Asia Pacific Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
6.5.1.22. Rest of Asia Pacific Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
6.5.1.23. Rest of Asia Pacific Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
6.5.1.24. Rest of Asia Pacific Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, 2019-2032
7.1. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Natural
7.1.1.2. Artificial
7.1.1.3. Nutritive
7.1.1.4. Non- nutritive
7.1.1.5. Polyols
7.1.1.6. Others
7.2. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2019-2032
7.2.1.1. Hot Melt Extrusion
7.2.1.2. Microencapsulation
7.2.1.3. Coating
7.2.1.4. Organoleptic Methods
7.2.1.5. Others
7.3. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Solid Dosage Forms
7.3.1.1.1. Tablets
7.3.1.1.2. Granules
7.3.1.1.3. Capsules
7.3.1.2. Liquid Dosage Forms
7.4. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Pharmaceuticals
7.4.1.2. Nutraceuticals
7.4.1.3. Contract Manufacturing Organizations
7.5. Latin America Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Brazil Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
7.5.1.2. Brazil Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
7.5.1.3. Brazil Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
7.5.1.4. Brazil Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
7.5.1.5. Mexico Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
7.5.1.6. Mexico Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
7.5.1.7. Mexico Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
7.5.1.8. Mexico Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
7.5.1.9. Argentina Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
7.5.1.10. Argentina Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
7.5.1.11. Argentina Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
7.5.1.12. Argentina Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
7.5.1.13. Rest of Latin America Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
7.5.1.14. Rest of Latin America Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
7.5.1.15. Rest of Latin America Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
7.5.1.16. Rest of Latin America Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, 2019-2032
8.1. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by Excipient, Value (US$ Mn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Natural
8.1.1.2. Artificial
8.1.1.3. Nutritive
8.1.1.4. Non- nutritive
8.1.1.5. Polyols
8.1.1.6. Others
8.2. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by Technique, Value (US$ Mn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Hot Melt Extrusion
8.2.1.2. Microencapsulation
8.2.1.3. Coating
8.2.1.4. Organoleptic Methods
8.2.1.5. Others
8.3. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by Usage, Value (US$ Mn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Solid Dosage Forms
8.3.1.1.1. Tablets
8.3.1.1.2. Granules
8.3.1.1.3. Capsules
8.3.1.2. Liquid Dosage Forms
8.4. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by End User, Value (US$ Mn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Pharmaceuticals
8.4.1.2. Nutraceuticals
8.4.1.3. Contract Manufacturing Organizations
8.5. Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Outlook, by Country, Value (US$ Mn), 2019-2032
8.5.1. Key Highlights
8.5.1.1. GCC Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
8.5.1.2. GCC Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
8.5.1.3. GCC Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
8.5.1.4. GCC Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
8.5.1.5. South Africa Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
8.5.1.6. South Africa Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
8.5.1.7. South Africa Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
8.5.1.8. South Africa Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
8.5.1.9. Egypt Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
8.5.1.10. Egypt Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
8.5.1.11. Egypt Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
8.5.1.12. Egypt Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
8.5.1.13. Nigeria Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
8.5.1.14. Nigeria Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
8.5.1.15. Nigeria Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
8.5.1.16. Nigeria Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
8.5.1.17. Rest of Middle East & Africa Pharmaceutical Excipients for Taste Masking Market by Excipient, Value (US$ Mn), 2019-2032
8.5.1.18. Rest of Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Indication, Value (US$ Mn), 2019-2032
8.5.1.19. Rest of Middle East & Africa Pharmaceutical Excipients for Taste Masking Market Artery Type, Value (US$ Mn), 2019-2032
8.5.1.20. Rest of Middle East & Africa Pharmaceutical Excipients for Taste Masking Market End User, Value (US$ Mn), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Artery Type vs Indication Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Roquette Frères
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Rochem International, Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Gattefose
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Asahi Kasei Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. DuPont de Nemours, Inc
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Cardinal Health Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Dow Pharma Solutions
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. SPI Pharma, Inc
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. GPT Pharmaceuticals Pvt.Ltd
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Adare Pharmaceuticals Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • SPI Pharma, Inc.
  • Adare Pharmaceutical Inc.
  • GPT Pharmaceuticals Pvt. Ltd
  • Roquette Frères
  • Rochem International, Inc.
  • Gattefose
  • Asahi Kasei Corporation
  • DuPont de Nemours, Inc
  • Dow Pharma Solutions